Delivery Order SPE2DB24D9803-SPE2DB25FJSDB
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,958.88 on August 21, 2025, for HUMIRA (adalimumab) pens containing 40 mg/0.4 mL. The order, with an ultimate completion date of August 22, 2025, was issued by the Defense Logistics Agency under a firm fixed-price contract type with no set-aside designation. Performance of the delivery will take place in Conshohocken, Pennsylvania. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,489.92 by the Defense Logistics Agency on July 30, 2025, for the supply of HUMIRA (Adalimumab) CF Pen 40 mg/0.4 ml. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for ultimate completion by July 31, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $12,168.60 firm fixed-price delivery order by the Defense Logistics Agency on September 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This delivery order, with an ultimate completion date of September 8, 2025, represents a discrete purchase under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a $9,450.05 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with an ultimate completion date of September 17, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order with place of performance in Conshohocken, Pennsylvania. This award was made without set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $2,433.72 to DMS Pharmaceutical Group Inc. for HUMIRA Pen 40 mg/0.8 mL units on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. HUMIRA (adalimumab) is a widely-used biologic medication primarily prescribed for treating rheumatoid arthritis, psoriasis, and other...
- The Defense Logistics Agency awarded a delivery order valued at $4,056.20 to DMS Pharmaceutical Group Inc. for HUMIRA (CF) Pen 40 mg/0.4 mL on July 15, 2025, with a completion date of July 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order represents a procurement of the branded immunosuppressant medication used to treat...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,613.94 by the Defense Logistics Agency on April 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $12,168.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, with no set-aside designation applied. The product will be delivered to Park Ridge, Illinois, and represents a pharmaceutical...
- This is a $31,320.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the supply of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with an ultimate completion date of September 21, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency for HUMIRA (CF) Pen 40 mg/0.4 mls, valued at $5,315.34. The contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order represents pharmaceutical supply to support Department of Defense healthcare...
- SPE2DB24D9803Indefinite Delivery Contract
- SPE2DB24D9803-SPE2DB25FJSDBDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,244.96 to DMS Pharmaceutical Group Inc. for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL on April 24, 2025, with an ultimate completion date of April 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the company's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including biologics, prescription medications, and medical consumables, to support the medical supply needs of Department of Defense healthcare facilities worldwide. As a established federal contractor with a robust portfolio of pharmaceutical deliveries since 2001, DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of pharmaceutical products to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/24/25 |